RADNOR, Pa., March 26, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Integral Ad Science Holding Corp. (“IAS”) (NASDAQ: IAS) on behalf of those who purchased or otherwise acquired IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is March 31, 2025.
CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:
If you suffered IAS losses, you may CLICK HERE or copy and paste the following link into your browser: https://www.ktmc.com/new-cases/integral-ad-science-holding-corp?utm_source=PR&utm_medium=link&utm_campaign=ias&mktm=r
You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at info@ktmc.com.
DEFENDANTS’ ALLEGED MISCONDUCT:
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, Defendants misrepresented and/or failed to disclose that: (1) IAS was experiencing increased competitive pricing pressures and, as a result, IAS had been forced to cut prices to compensate for weakening demand and slowing revenue growth; (2) IAS’s pricing function was no longer “favorable” and IAS could not sustain its pricing or drive price increases; (3) pricing had become a key differentiator between IAS and its competitor, and IAS’s “favorable” pricing became necessary to close major renewals and new deals; (4) the risk that competition “could result in increased pricing pressure” or “could put pressure on us to change our prices” had in fact transpired; and (5) as a result, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
THE LEAD PLAINTIFF PROCESS:
IAS investors may, no later than March 31, 2025, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.
Kessler Topaz Meltzer & Check, LLP encourages IAS investors who have suffered significant losses to contact the firm directly to acquire more information.
CLICK HERE TO SIGN UP FOR THE CASE OR GO TO: https://www.ktmc.com/new-cases/integral-ad-science-holding-corp?utm_source=PR&utm_medium=link&utm_campaign=ias&mktm=r
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world. The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.
CONTACT:
Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
info@ktmc.com
May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.
- Dojo Fresh Brings Plant-Based Protein to More Meals With Support From the Non-GMO Project - May 15, 2025
- HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results - May 15, 2025
- Moody’s Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy - May 15, 2025
